AVTX short interest
Avalo Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 11,405,304 |
|---|---|
| Change vs prior report | -1,520,565 (-11.8%) |
| Change over six months | +105.8% |
| Days to cover | 8.80 (sector: 3.78) |
| Average daily volume | 1,296,416 |
| Rank in Healthcare | #162 of 922 by days to cover |
AVTX short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 11,405,304 | -11.8% | 8.80 | 1,296,416 |
| 2026-09-15 | 12,925,869 | +4.3% | 13.24 | 976,376 |
| 2026-08-31 | 12,387,012 | -5.4% | 15.17 | 816,596 |
| 2026-08-14 | 13,092,767 | +1.1% | 20.23 | 647,143 |
| 2026-07-31 | 12,950,314 | +2.1% | 14.38 | 900,454 |
| 2026-07-15 | 12,679,040 | +3.0% | 10.68 | 1,186,742 |
| 2026-06-30 | 12,307,967 | +66.0% | 4.26 | 2,887,428 |
| 2026-06-15 | 7,413,562 | +16.2% | 5.53 | 1,340,030 |
| 2026-05-29 | 6,382,270 | +2.0% | 4.36 | 1,464,002 |
| 2026-05-15 | 6,254,061 | +9.1% | 1.59 | 3,938,711 |
| 2026-04-30 | 5,733,586 | +9.5% | 8.10 | 708,216 |
| 2026-04-15 | 5,237,740 | -5.5% | 6.12 | 855,154 |
| 2026-03-31 | 5,542,400 | +35.5% | 6.21 | 892,659 |
| 2026-03-13 | 4,089,262 | +11.1% | 5.83 | 701,975 |
| 2026-02-27 | 3,681,926 | +2.4% | 7.21 | 510,549 |
| 2026-02-13 | 3,597,176 | +13.0% | 9.44 | 381,153 |
| 2026-01-30 | 3,183,754 | +6.8% | 8.13 | 391,774 |
| 2026-01-15 | 2,979,688 | +16.0% | 10.17 | 293,109 |
| 2025-12-31 | 2,568,740 | +38.2% | 7.56 | 339,981 |
| 2025-12-15 | 1,858,418 | +0.5% | 5.96 | 311,900 |
| 2025-11-28 | 1,848,452 | +0.5% | 5.23 | 353,682 |
| 2025-11-14 | 1,840,260 | +36.8% | 4.84 | 380,014 |
| 2025-10-31 | 1,345,096 | +3.3% | 3.27 | 411,674 |
| 2025-10-15 | 1,302,301 | +4.8% | 4.04 | 322,356 |
| 2025-09-30 | 1,242,948 | +513.9% | 2.01 | 618,519 |
import finzdata as yf
yf.Ticker("AVTX").short_interest # every report since 2017
yf.Client().short_interest(["AVTX"], start="2018-01-01")Healthcare short interest · AVTX price history · Who owns AVTX · All short interest